• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关注变异株与疫苗接种状况之间的新冠病毒传播性比较。

SARS-CoV-2 transmissibility compared between variants of concern and vaccination status.

作者信息

Wang Liang, Didelot Xavier, Bi Yuhai, Gao George F

机构信息

Institute of Microbiology, Chinese Academy of Sciences.

School of Life Sciences and Department of Statistics, University of Warwick.

出版信息

Brief Bioinform. 2022 Mar 10;23(2). doi: 10.1093/bib/bbab594.

DOI:10.1093/bib/bbab594
PMID:35062017
Abstract

Since the start of the SARS-CoV-2 pandemic in late 2019, several variants of concern (VOC) have been reported to have increased transmissibility. In addition, despite the progress of vaccination against SARS-CoV-2 worldwide, all vaccines currently in used are known to protect only partially from infection and onward transmission. We combined phylogenetic analysis with Bayesian inference under an epidemiological model to infer the reproduction number (Rt) and also trace person-to-person transmission. We examined the impact of phylogenetic uncertainty and sampling bias on the estimation. Our result indicated that lineage B had a significantly higher transmissibility than lineage A and contributed to the global pandemic to a large extent. In addition, although the transmissibility of VOCs is higher than other exponentially growing lineages, this difference is not very high. The probability of detecting onward transmission from patients infected with SARS-CoV-2 VOCs who had received at least one dose of vaccine was approximate 1.06% (3/284), which was slightly lower but not statistically significantly different from a probability of 1.21% (10/828) for unvaccinated individuals. In addition to VOCs, exponentially growing lineages in each country should also be account for when tailoring prevention and control strategies. One dose of vaccination could not efficiently prevent the onward transmission of SARS-CoV-2 VOCs. Consequently, nonpharmaceutical interventions (such as wearing masks and social distancing) should still be implemented in each country during the vaccination period.

摘要

自2019年末新型冠状病毒肺炎疫情开始以来,据报道几种值得关注的变异株(VOC)的传播力有所增强。此外,尽管全球范围内针对新型冠状病毒的疫苗接种取得了进展,但目前所有正在使用的疫苗都仅能部分预防感染和后续传播。我们将系统发育分析与流行病学模型下的贝叶斯推断相结合,以推断再生数(Rt)并追踪人际传播。我们研究了系统发育不确定性和抽样偏差对估计的影响。我们的结果表明,B谱系的传播力明显高于A谱系,并在很大程度上促成了全球疫情。此外,尽管VOC的传播力高于其他呈指数增长的谱系,但这种差异并不是很大。在至少接种过一剂疫苗的感染新型冠状病毒VOC的患者中检测到后续传播的概率约为1.06%(3/284),略低于未接种疫苗个体的1.21%(10/828),但在统计学上无显著差异。除了VOC之外,在制定预防和控制策略时,还应考虑每个国家呈指数增长的谱系。一剂疫苗不能有效预防新型冠状病毒VOC的后续传播。因此,在疫苗接种期间,每个国家仍应实施非药物干预措施(如戴口罩和保持社交距离)。

相似文献

1
SARS-CoV-2 transmissibility compared between variants of concern and vaccination status.关注变异株与疫苗接种状况之间的新冠病毒传播性比较。
Brief Bioinform. 2022 Mar 10;23(2). doi: 10.1093/bib/bbab594.
2
Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants.新型 SARS-CoV-2 变异株的进化、传播模式和突变特征。
mBio. 2021 Aug 31;12(4):e0114021. doi: 10.1128/mBio.01140-21.
3
Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.2021 年初全球 COVID-19 大流行期间,低和高疫苗接种率国家中 SARS-CoV-2 变体的单倍型分布。
Infect Genet Evol. 2022 Jan;97:105164. doi: 10.1016/j.meegid.2021.105164. Epub 2021 Nov 27.
4
Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.关注的紧急 SARS-CoV-2 变异株:用于快速检测和监测的新型多重实时 RT-PCR 检测方法。
Microbiol Spectr. 2022 Feb 23;10(1):e0251321. doi: 10.1128/spectrum.02513-21.
5
Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.关注的 B.1.351 和 B.1.1.7 SARS-CoV-2 变异株的复制动力学,包括评估携带 ORF7a 基因缺陷的 B.1.1.7 突变体。
Viruses. 2021 Jun 7;13(6):1087. doi: 10.3390/v13061087.
6
Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.意大利医护人员感染有症状的 SARS-CoV-2 VOC 202012/01 谱系 B.1.1.7 的暴发调查。
Clin Microbiol Infect. 2021 Aug;27(8):1174.e1-1174.e4. doi: 10.1016/j.cmi.2021.05.007. Epub 2021 May 10.
7
SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence.SARS-CoV-2 变体和疫苗效力:当前证据综述。
Epidemiol Infect. 2021 Nov 4;149:e237. doi: 10.1017/S0950268821002430.
8
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.评估 SARS-CoV-2 谱系 B.1.1.7 在英国的传播能力。
Nature. 2021 May;593(7858):266-269. doi: 10.1038/s41586-021-03470-x. Epub 2021 Mar 25.
9
Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico.墨西哥蒙特雷一家医院 COVID-19 突破性感染中关注的 SARS-CoV-2 变异株和感兴趣的变异株的流行情况。
Viruses. 2022 Jan 14;14(1):154. doi: 10.3390/v14010154.
10
Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.开发扩增抑制突变系统-实时荧光定量 RT-PCR 检测方法,快速灵敏地筛查关注的 SARS-CoV-2 变异株。
Microbiol Spectr. 2022 Feb 23;10(1):e0143821. doi: 10.1128/spectrum.01438-21. Epub 2022 Jan 5.

引用本文的文献

1
The "Wolf" Is Indeed Coming: Recombinant "Deltacron" SARS-CoV-2 Detected.“狼”真的来了:检测到重组“德尔塔克戎”新冠病毒。
China CDC Wkly. 2022 Apr 8;4(14):285-287. doi: 10.46234/ccdcw2022.054.